Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Cited by (893)

Items 401–500 of 893

1. Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging
   Dawei Yang, Dan Li, Jinshui Li, Zhenghan Yang, Zhenchang Wang · 2020 · European Journal of Radiology
2. La Estoria de España de Alfonso X: creación y evolución
   Diego Catalán · 1992
3. Clinical relevance of shear wave elastography compared with transient elastography and other markers of liver fibrosis
   Oyekoya Taiwo Ayonrinde, Marilyn Zelesco, Chris J. Welman, S. Abbott, Niwansa Adris · 2021 · Internal Medicine Journal
4. Evaluation of blood‐based PRO‐C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta‐analysis
   Menglu Liu, Hanying Qiu, Wenyan Zhang, Tingting Mei, Shan Tang, Yuxue Gao, Yanqiu Zhu, Xiaojie Huang, Haibin Yu · 2023 · Journal of Gastroenterology and Hepatology
5. Role of aspartate aminotransferase to platelet ratio in the prediction and prognosis of intrahepatic cholestasis of pregnancy: A case–control study from a tertiary center
   Ayça Peker, Atakan Tanaçan, Göksun İpek, Zahid Ağaoğlu, Dilek Şahın · 2023 · International Journal of Gynecology & Obstetrics
6. Application and Diagnostic Performance of Two-Dimensional Shear Wave Elastography and Liver Fibrosis Scores in Adults with Class 3 Obesity
   Ritesh Chimoriya, Vincent Ho, Ziqi Vincent Wang, Ruby Chang, Badwi B. Boumelhem, David S Simmons, Nic Kormas, Mark D. Gorrell, Milan K. Piya · 2023 · Nutrients
7. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease
   Monica A. Tincopa, Rohit Seth Loomba · 2024 · Seminars in Liver Disease
8. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies
   Tian Lan, Frank Tacke · 2024 · Metabolism
9. Multi-cellular transitional organotypic models to investigate liver fibrosis
   Sophia M. Orbach, Andrew J. Ford, Scott-Eugene Saverot, Padmavathy Rajagopalan · 2018 · Acta Biomaterialia
10. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study
    Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca V. C. Valenti, Guido Ligabue, Susanna Schianchi et al. · 2021 · Diabetes Research and Clinical Practice
11. Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care
    Anastasia‐Stefania Alexopoulos, Ryan Duffy, Elizabeth A. Kobe, Jashalynn German, Cynthia A. Moylan, Diana Soliman, Amy S. Jeffreys, Cynthia J. Coffman, Matthew J. Crowley · 2021 · Journal of the Endocrine Society
12. Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care
    Martin Bergram, Patrik Nasr, Fredrik Iredahl, Stergios Kechagias, Karin Rådholm, Mattias Ekstedt · 2021 · Scandinavian Journal of Gastroenterology
13. Cumulative Betel Quid Chewing and the Risk of Significant Liver Fibrosis in Subjects With and Without Metabolic Syndrome
    Yu-Tsung Chou, Zih‐Jie Sun, Wei-Chen Shen, Yi‐Ching Yang, Feng-Hwa Lu, Chih‐Jen Chang, Chung‐Yi Li, Jin‐Shang Wu · 2022 · Frontiers in Nutrition
14. Effect of Ramadan fasting on hepatic steatosis as quantified by controlled attenuation parameter (CAP): a prospective observational study
    Ahmed Ibrahim Gad, Hesham Atia Abdel-Ghani, Amir Abd-elhameed Ahmed Barakat · 2022 · Egyptian Liver Journal
15. Quantitative shear wave elastography compared to standard ultrasound (qualitative B-mode grayscale sonography and quantitative power Doppler) for evaluation of achillotendinopathy in treatment-naïve individuals: A cross-sectional study
    Lixiu Chen, Ying Cheng, Liang Zhou, Lei Zhang, Xueyan Deng · 2022 · Advances in Clinical and Experimental Medicine
16. Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
    Thierry Poynard, Valentina Peta, Olivier Deckmyn, Raluca Pais, Yen Ngo, Frédéric Charlotte, An Ngo, Mona Munteanu, Françoise Imbert‐Bismut, Denis Monneret et al. · 2019 · European Journal of Gastroenterology & Hepatology
17. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease
    Hemnishil K. Marella, Yala Kirthi Reddy, Yu Jiang, Surosree Ganguli, Pradeep S. B. Podila, Peter D. Snell, Alexander J. Kovalic, George T. Cholankeril, Ashwani Kumar Singal, Satheesh P. Nair et al. · 2020 · Clinical and Translational Gastroenterology
18. Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD
    Laurent Castéra, Jérôme Boursier · 2022 · Seminars in Liver Disease
19. Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD
    Ling Luo, Congxiang Shao, Long Teng, Shuyu Zhuo, Zhi Dong, Wei J. Wang, Junzhao Ye, Bihui Zhong · 2025 · BMJ Open Gastroenterology
20. Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes
    Luigi Elio Adinolfi, Aldo Marrone, Antonio Izzi, Antonio Craxı̀ · 2025 · Journal of Clinical and Experimental Hepatology
21. FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinoma
    Kenji Imai, Koji Takai, Shinji Unome, Takao Miwa, Tatsunori Hanai, Atsushi Suetsugu, Masahito Shimizu · 2023 · Molecular and Clinical Oncology
22. Molecular imaging of macrophage composition and dynamics in MASLD
    Bin Q. Yang, Mandy M. Chan, Gyu Seong Heo, Lanlan Lou, Hannah P. Luehmann, Christopher Park, Alexandria Li, Divangana Lahad, Deborah H. Sultan, Peter Voller et al. · 2024 · JHEP Reports
23. Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES 2017–2020
    Yuou Ying, Yuan Ji, Ruyi Ju, Jinhan Chen, Mingxian Chen · 2025 · BMC Gastroenterology
24. Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scores
    Fabio Novielli, Carlo De Matteis, Antonio Moschetta, Lucilla Crudele · 2025 · Expert Review of Gastroenterology & Hepatology
25. Gadoxetate-disodium-enhanced magnetic resonance imaging for liver fibrosis staging: a systematic review and meta-analysis
    X. Li, H. Liu, R. Wang, Jian Yang, Yuchen Zhang, C. Li · 2019 · Clinical Radiology
26. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup
    Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Sakura Kirino, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa et al. · 2020 · International Journal of Molecular Sciences
27. Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort
    Andrew D. Schreiner, Sherry Livingston, Jingwen Zhang, Mulugeta Gebregziabher, Justin E. Marsden, David Koch, Chelsey A. Petz, Valerie L. Durkalski‐Mauldin, Patrick D. Mauldin, William P. Moran · 2021 · Journal of Clinical Gastroenterology
28. Diagnosis of liver cirrhosis with two-dimensional shear wave elastography in biliary atresia before Kasai portoenterostomy
    Cailin Ding, Zengmeng Wang, Chunhui Peng, Wenbo Pang, Sarah Siyin Tan, Yajun Chen · 2021 · Pediatric Surgery International
29. Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis
    Subin Heo, Dong Wook Kim, Sang Hyun Choi, Seong Woo Kim, Jong Keon Jang · 2022 · European Radiology
30. The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores—An 11.6-Year Follow-Up Study
    Elfrid Christine Smith Sandvik, Kristin Matre Aasarød, Gjermund Johnsen, Dag Arne Lihaug Hoff, Bård Eirik Kulseng, Åsne Ask Hyldmo, Hallvard Græslie, Siren Nymo, Jorunn Sandvik, Reidar Fossmark · 2022 · Journal of Clinical Medicine
31. Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis
    Thierry Poynard, Olivier Deckmyn, Valentina Peta, Valérie Paradis, Jean–François Gautier, Angélique Brzustowski, Pierre Bédossa, Laurent Castéra, Stanislas Pol, Dominique Charles Valla · 2023 · Alimentary Pharmacology & Therapeutics
32. FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
    Yuping Ding, Zuoyu Wang, Haiyan Niu, Quanjun Deng, Yanan Wang, Shihai Xia · 2023 · Medicine
33. Association of thyroid function with non‐alcoholic fatty liver disease in recent‐onset diabetes
    Nina Saatmann, Martin Schön, Oana‐Patricia Zaharia, Maximilian Huttasch, Klaus Straßburger, Sandra Trenkamp, Yuliya Kupriyanova, Vera B. Schrauwen‐Hinderling, SABINE KAHL, Volker Burkart et al. · 2023 · Liver International
34. Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients
    Pimsiri Sripongpun, Pisit Tangkijvanich, Watcharasak Chotiyaputta, Phunchai Charatcharoenwitthaya, Roongruedee Chaiteerakij, Sombat Treeprasertsuk, Chalermrat Bunchorntavakul, Abhasnee Sobhonslidsuk, Apinya Leerapun, Suparat Khemnark et al. · 2019 · JGH Open
35. Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
    Eddison Godinez Leiva, Fernando Bril · 2020 · Current Hypertension Reviews
36. Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review
    Marcio José Concepción‐Zavaleta, Jenyfer María Fuentes‐Mendoza, Jhean Gabriel Gonzáles Yovera, Gemma Y Ruvalcaba-Barbosa, Leonardo D Cura-Rodríguez, Josué S González-Rodríguez, Luis Alberto Concepción Urteaga, Aranza I Pérez-Reyes, Juan Eduardo Quiroz Aldave, José Paz‐Ibarra · 2025 · World Journal of Gastroenterology
37. Diagnostic performance of elastosonography in the differential diagnosis of benign and malignant salivary gland tumors: A meta-analysis
    Jiangfeng Wu, Zhijuan Zhou, Xiaoyun Wang, Yun Jin, Zhengping Wang, Guilong Jin · 2022 · Frontiers in Oncology
38. Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population
    Mimi Kim, Eileen Laureal Yoon, Jonghyun Lee, Seon Cho, Chul‐min Lee, Bo-Kyeong Kang, Huiyul Park, Dae Won Jun, Eun‐Hee Nah · 2022 · Clinical Gastroenterology and Hepatology
39. Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study
    Marcin Hachuła, Michał Kosowski, Marcin Basiak, Bogusław Okopień · 2023 · Pharmaceuticals
40. Assessment of aspartate aminotransferase to Platelet Ratio Index and Fibrosis-4 Index score on women with intrahepatic cholestasis of pregnancy
    Maria Cemortan, Corina Iliadi-Tulbure, Irina Sagaidac, Olga Cernetchi · 2024 · AJOG Global Reports
41. Diagnosis and Management of MASLD: An Metabolic Perspective of a Multisystem Disease
    Vanishri Ganakumar, Tejaswi Halebidu, Manjunath Goroshi, Vikrant Ghatnatti · 2024 · International journal of clinical metabolism and diabetes.
42. Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis
    Jiaxin Zhao, Huiying Zhou, Rui Wu, Chen Ruan, Cheng Wang, Jiawei Ding, Tao Zhang, Zheyu Fang, Huilin Zheng, Lei Zhang et al. · 2024 · Annals of Hepatology
43. Long‐Term Risk of Inflammatory Bowel Disease With MASLD: A Large‐Scale Prospective Cohort Study in UK Biobank
    Qian Zhang, Fang Xu, Zuyao Wang, Si Liu, Shengtao Zhu, Shutian Zhang, Shanshan Wu · 2025 · Journal of Gastroenterology and Hepatology
44. Diagnostic Value of Ultrasound in Fatty Liver Disease
    Thomas Karlas, Valentin Blank, Albrecht Böhlig · 2021 · Ultraschall in der Medizin - European Journal of Ultrasound
45. Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease
    Miwa Kawanaka, Ken Nishino, Katsunori Ishii, Tomohiro Tanikawa, Noriyo Urata, Mitsuhiko Suehiro, Takako Sasai, Ken Haruma, Hirofumi Kawamoto · 2021 · World Journal of Hepatology
46. Combined Transcriptomic and Lipidomic Analysis Reveals Dysregulated Genes Expression and Lipid Metabolism Profiles in the Early Stage of Fatty Liver Disease in Rats
    Ruina Zhai, Lei Feng, Yu Zhang, Wei Liu, Shengli Li, Zhiyong Hu · 2021 · Frontiers in Nutrition
47. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
    Chih‐Lin Lin, Chi‐Ming Tai, Jee‐Fu Huang, Chun‐Jen Liu, Hui‐Fen Chen, Pin‐Nan Cheng, Chi-Yi Chen, Cheng‐Yuan Peng, Chia‐Chi Wang, Shih‐Han Weng et al. · 2022 · Journal of Gastroenterology and Hepatology
48. Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection
    Naomi Ideno, Akito Nozaki, Makoto Chuma, Katsuaki Ogushi, Koji Hara, Satoshi Moriya, Hiroyuki Fukuda, Kazushi Numata, Shin Maeda · 2022 · European Journal of Gastroenterology & Hepatology
49. Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?
    Lei Zhang, Yilei Mao · 2022 · Healthcare
50. Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes
    Seung Min Chung, Min Kyu Kang, Jun Sung Moon, Jung Gil Park · 2023 · Endocrinology and Metabolism
51. Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: a single-center experience.
    Ahmed Ibrahim Gad, Mohamed Rezk Elmedames, Ayman Ramadan Abdelhai, Ayman Mohamed Marei, Hesham Atia Abdel-Ghani · 2021 · Gastroenterology and hepatology from bed to bench.
52. Use of Texture Analysis on Noncontrast MRI in Classification of Early Stage of Liver Fibrosis
    Ru Zhao, Xijun Gong, Yaqiong Ge, Hong Zhao, Longsheng Wang, Hongzhen Yu, Bin Liu · 2021 · Canadian Journal of Gastroenterology and Hepatology
53. Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice
    Saleh A. Alqahtani, Jörn Markus Schattenberg · 2021 · Expert Review of Molecular Diagnostics
54. Liver fibrosis scores and risk of liver‐related mortality in young adults with chronic hepatitis B: A cohort study
    Won Sohn, Yoosoo Chang, Yong Kyun Cho, Yun Soo Hong, Ho Cheol Shin, Seungho Ryu · 2021 · Journal of Viral Hepatitis
55. Shear Wave Elastography Reveals a High Prevalence of NAFLD-related Fibrosis even in Type 1 Diabetes
    Gesine Meyer, Nina Dauth, Matthias Grimm, Eva Maria Herrmann, Joerg Bojunga, Mireen Friedrich‐Rust · 2021 · Experimental and Clinical Endocrinology & Diabetes
56. Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD
    Yamini Natarajan, Rohit Seth Loomba · 2021 · Journal of Clinical and Experimental Hepatology
57. Inter-platform Variability of Liver Elastography: Pairwise Comparisons of Four Devices
    Christophe Cassinotto, Sophie Anselme, Tony Jacq, Marie Irlès‐Depé, Ali Belgour, Margaux Hermida, Boris Guiu, Victor de Lédinghen · 2022 · Ultrasound in Medicine & Biology
58. Significance of Fib4 index as an indicator of alcoholic hepatotoxicity in health examinations among Japanese male workers: a cross-sectional and retrospectively longitudinal study
    Hideki Shinoda, Yuya Watanabe, Kota Fukai, Kayoko Kasuya, Yuko Furuya, Shoko Nakazawa, Toru Honda, Takeshi Hayashi, Toru Nakagawa, Masayuki Tatemichi et al. · 2023 · European journal of medical research
59. Magnetic resonance imaging and ultrasound elastography in the context of preclinical pharmacological research: significance for the 3R principles
    Michael Obrecht, Stefan Zurbruegg, Nathalie Accart, Christian Lambert, Arno Doelemeyer, Birgit Ledermann, Nicolau Beckmann · 2023 · Frontiers in Pharmacology
60. Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study
    Fan Zhang, Yan Han, Yong-Hua Mao, Guojun Zheng, Longgen Liu, Wenjian Li · 2024 · Annals of Medicine
61. Noninvasive Methods for Assessing Liver Fibrosis and Steatosis.
    Iqra Kazi, Lily Kuo, Eugenia Tsai · 2024 · PubMed Central
62. Evaluation of hepatic injury in chronic hepatitis B and C using APRI and FIB-4 indices compared to fibroscan results
    Narges Najafi, Alireza Razavi, Hamed Jafarpour, Maedeh Raei, Zahra Azizi, Lotfollah Davoodi, Amirsaleh Abdollahi, Mehran Frouzanian · 2024 · Annals of Medicine and Surgery
63. Comparison of the diagnostic accuracy of shear wave elastography with transient elastography in adult nonalcoholic fatty liver disease: a systematic review and network meta-analysis of diagnostic test accuracy
    Ruri Yamaguchi, Tetsuro Oda, Kengo Nagashima · 2024 · Abdominal Radiology
64. Diagnostic accuracy of Agile‐4 score for liver cirrhosis in patients with metabolic dysfunction‐associated steatotic liver disease. A systematic review and meta‐analysis of diagnostic test accuracy studies
    Konstantinos Malandris, Anastasia Katsoula, Aris Liakos, Thomas Karagiannis, Emmanouil Sinakos, Όλγα Γιουλεμέ, Philippos Klonizakis, Eleni Theocharidou, Eleni Gigi, Eleni Bekiari et al. · 2024 · Diabetes Obesity and Metabolism
65. The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis
    Riccardo Righetti, Felice Cinque, Keyur Patel, Giada Sebastiani · 2025 · Expert Review of Gastroenterology & Hepatology
66. Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
    Antonio Liguori, Giorgio Esposto, Maria Elena Ainora, Irene Mignini, Raffaele Borriello, Linda Galasso, Mattia Paratore, Maria Cristina Giustiniani, Laura Riccardi, Matteo Garcovich et al. · 2025 · Biomedicines
67. Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes
    Farooq Ahmad Khan, Stafny Dsouza, Amar Hassan Khamis, Fatima Abdul, Muhammad H. Farooqi, Fatima Sulaiman, Fahad Mulla, Fatheya Alawadi, Mohamed M. Hassanein, Riad Bayoumi · 2025 · Journal of General Internal Medicine
68. Metabolic Dysfunction-Associated Steatotic Liver Disease in the Korean General Population: Epidemiology, Risk Factors, and Non-Invasive Screening
    Yong Jun Choi, Joo-Heon Park, Han-Ik Cho, Myung‐Geun Shin, Eun‐Hee Nah · 2025 · Metabolites
69. Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease
    Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu‐Sang Park · 2021 · Gut and Liver
70. Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver
    Huiyul Park, Eileen Laureal Yoon, Mimi Kim, Jung Hwan Kim, Seon Cho, Dae Won Jun, Eun‐Hee Nah · 2021 · Journal of Clinical Medicine
71. Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus
    Weijia Han, Chunyang Huang, Yali Ji, Ling Zhou, Jinjun Chen, Jinlin Hou · 2021 · Frontiers in Medicine
72. Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease
    Katherine J. P. Schwenger, Maryam Alali, Yasaman Ghorbani, Sandra Elisabeth Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard · 2022 · Obesity Surgery
73. Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
    Yiwen Shi, Jian‐Gao Fan · 2022 · Clinical and Molecular Hepatology
74. MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
    Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang et al. · 2023 · Journal of Gastroenterology and Hepatology
75. Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD
    Rohit Seth Loomba, Alnoor S. Ramji, Tarek Hassanein, Eric M. Yoshida, Emily Pang, Caitlin Schneider, Michael P. Curry, Nezam H. Afdhal · 2024 · Hepatology Communications
76. Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factors
    Muharrem Bayrak · 2020 · The Aging Male
77. The diagnostic conundrum in non-alcoholic fatty liver disease
    Valerio Rosato, Mario Masarone, Andrea Aglitti, Marcello Persico · 2020 · Exploration of Medicine
78. A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones
    Yu-Tsung Chou, Chung‐Hao Li, Zih‐Jie Sun, Wei-Chen Shen, Yi‐Ching Yang, Feng‐Hwa Lu, Chih‐Jen Chang, Jin‐Shang Wu · 2021 · Nutrients
79. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population
    Ming‐Hui Zhao, Yanli Hu, Changcheng Shi, K. Wang, Jia‐Su Li, Jiahui Song, C. Huo, Yingfei Xi, Shizhong Bu, Qinghai Huang · 2021 · Public Health
80. The association of low‐grade albuminuria with incident non‐alcoholic fatty liver disease and non‐invasive markers of liver fibrosis by glycaemia status
    Zhuojun Xin, Shanshan Liu, Jingya Niu, Min Xu, Tiange Wang, Jieli Lu, Yuhong Chen, Weiqing Wang, Guang Ning, Yufang Bi et al. · 2020 · Liver International
81. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity
    Valeria Calcaterra, Vittoria Carlotta Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino et al. · 2022 · Children
82. Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes
    Ariane De Villers-Lacasse, Martine Paquette, Alexis Wilfrid Baass, Sophie Bernard · 2023 · Journal of clinical lipidology
83. Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective
    Claudio Tana, Cosima Schiavone, Andrea Ticinesi, Fulvio Lauretani, Antonio Nouvenne, Christoph Frank Dietrich, Tiziana Meschi · 2018 · International Journal of Immunopathology and Pharmacology
84. A 2-step fast-track elastometry service for advanced workup of nonalcoholic fatty liver disease (NAFLD) patients – single-center real-world experience of outpatient clinical practice
    Mohamed Alsenbesy, Monika Rau, Johannes Weiß, Oliver Götze, Andreas Geier · 2019 · Zeitschrift für Gastroenterologie
85. Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes
    Alshaima Alhinai, Keyur Patel, Vivian Andrew Fonseca, Giada Sebastiani · 2021 · Journal of Diabetes and its Complications
86. Fibrosis-4 index is closely associated with clinical outcomes in acute cardioembolic stroke patients with nonvalvular atrial fibrillation
    Yang Lei, Ke Gao, Rui-Juan Shi, Yu-Nan Qin, Xiao-Rui Huang, Yajie Gao, Xiaopu Zheng · 2023 · Internal and Emergency Medicine
87. Association of liver fibrosis with cognitive decline in Parkinson’s disease
    Aryeh Zolin, Cenai Zhang, Hwai Yin Ooi, Harini Sarva, Hooman Kamel, Neal S. Parikh · 2023 · Journal of Clinical Neuroscience
88. Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Tanvi Goyal, Michael W. Song, Deepika Suresh, Venkata Sai J. Jasty, Esteban Urias, Karn Wijarnpreecha, Yu Jun Wong, Vincent Lingzhi Chen · 2024 · Digestive Diseases and Sciences
89. Association between mixed exposure of non-persistent pesticides and liver fibrosis in the general US population: NHANES 2013–2016
    Shuge Shu, Yuan Li, Xiangyu Yu, Xinting Chen, U Abdullah, Yongquan Yu · 2025 · Ecotoxicology and Environmental Safety
90. Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
    Lampros Chrysavgis, Niki G. Mourelatou, Εvangelos Cholongitas · 2025 · Biomedicines
91. Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs
    Daniel Clayton‐Chubb, William W. Kemp, Ammar Majeed, Peter W. Lange, Jessica A. Fitzpatrick, Karl Vaz, John Samuel Lubel, Alexander D. Hodge, Joanne L. Ryan, John J. McNeil et al. · 2025 · Nutrients
92. Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease
    Maryam Moini, Fernanda de Quadros Onófrio, Bettina E. Hansen, Oyedele Adewale Adeyi, Korosh Khalili, Keyur Patel · 2021 · Scientific Reports
93. The Value of High-Resolution Ultrasound Combined with Shear-Wave Elastography under Artificial Intelligence Algorithm in Quantitative Evaluation of Skin Thickness in Localized Scleroderma
    Kun Jia, Huiying Li, Xiaojing Wu, Caina Xu, Hongyuan Xue · 2022 · Computational Intelligence and Neuroscience
94. Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB‐4 index in metabolic‐associated fatty liver disease
    Masaaki Mino, Eiji Kakazu, Akitoshi Sano, Hisayuki Katsuyama, Mariko Hakoshima, Hidekatsu Yanai, Yoshihiko Aoki, Masatoshi Imamura, Taiji Yamazoe, Taizo Mori et al. · 2023 · Hepatology Research
95. Liver stiffness is associated with all‐cause mortality in patients with NAFLD : A systematic review and meta‐analysis
    Stefano Ciardullo, Emanuele Muraca, Francesca Zerbini, Gianluca Perseghin · 2023 · Liver International
96. Probiotics may be useful for drug-induced liver dysfunction in patients with depression – A secondary analysis of a randomized clinical trial
    Oliwia Gawlik-Kotelnicka, Jacek Burzyński, Jakub Krzysztof Rogalski, Anna Skowrońska, Dominik Strzelecki · 2024 · Clinical Nutrition ESPEN
97. Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
    Omar El‐Sherif, Matthew James Armstrong · 2019 · Seminars in Liver Disease
98. How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis
    Zachary H. Henry, Curtis Kent Argo · 2019 · Gastroenterology Clinics of North America
99. A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
    Heather Mary-Kathleen Kosick, Aline Keyrouz, Oyedele Adewale Adeyi, Giada Sebastiani, Keyur Patel · 2021 · Digestive Diseases and Sciences
100. Shear wave speeds in nearly-incompressible fibrous materials with two fiber families
     Zuoxian Hou, Philip V. Bayly, Ruth J. Okamoto · 2021 · The Journal of the Acoustical Society of America